Biogen Idec (Nasdaq: BIIB) announced that an arbitration panel has issued its decision concerning the Company's collaboration agreement with Genentech ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE